All Relations between Acromegaly and gh

Publication Sentence Publish Date Extraction Date Species
T Yasuda, M Kawasuji, N Sakakibara, K Ueyama, H Kasajima, Y Watanabe, M Ito, M Shimiz. [A case of left ventricular aneurysm associated with acromegaly]. Kyobu geka. The Japanese journal of thoracic surgery. vol 46. issue 7. 1993-08-20. PMID:8336439. in order to safely operate, it is important to control serum gh levels and pay special attention to the well-known complications of acromegaly such as diabetes mellitus and hypertension. 1993-08-20 2023-08-12 Not clear
S J Brockmeier, M Buchfelder, R Fahlbusc. TRH/GnRH test in acromegaly. Long-term follow-up experience with successfully treated patients. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. vol 25. issue 5. 1993-08-17. PMID:8330864. we investigated the rate of recurrence in acromegaly in 20 patients who were found to have a trh and gnrh induced gh response postoperatively after primarily successful transsphenoidal selective adenomectomy in a retrospective study. 1993-08-17 2023-08-12 Not clear
S J Brockmeier, M Buchfelder, R Fahlbusc. TRH/GnRH test in acromegaly. Long-term follow-up experience with successfully treated patients. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. vol 25. issue 5. 1993-08-17. PMID:8330864. we conclude that, in contrast to previous studies, a stimulation of gh in the trh/gnrh test does not necessarily predict likely recurrence of acromegaly in patients with an adequate suppression of gh during an ogtt following operative microsurgical treatment. 1993-08-17 2023-08-12 Not clear
P G Chiodini, R Attanasio, R Cozzi, D Dallabonzana, G Oppizzi, P Orlandi, S Strada, A Liuzz. CV 205-502 in acromegaly. Acta endocrinologica. vol 128. issue 5. 1993-07-23. PMID:8100375. we conclude that in acromegaly chronic treatment with this new dopaminergic drug has a gh- and prl-lowering effect that is similar to but more prolonged than that of bromocriptine, and normal or near-normal gh and igf-i levels may be obtained in a few patients with b.i.d. 1993-07-23 2023-08-12 Not clear
G Tallen, S Fehr, W Saeger, H Uhlig, D K Lüdeck. Detection of growth hormone, prolactin and human beta-chorionic gonadotropin mRNA in growth hormone-secreting pituitary adenomas and in prolactin-secreting pituitary adenomas by in situ hybridization using a non-isotopic detection method. Acta endocrinologica. vol 128. issue 5. 1993-07-23. PMID:8317187. a non-isotopic in situ hybridization method with digoxigenin-labelled probes was used to examine growth hormone (gh), prolactin (prl) and human beta-chorionic gonadotropin (beta-hcg(lh)) gene expression in 63 pituitary tumours in acromegaly and 20 adenomas in hyperprolactinaemia. 1993-07-23 2023-08-12 human
G Tallen, S Fehr, W Saeger, H Uhlig, D K Lüdeck. Detection of growth hormone, prolactin and human beta-chorionic gonadotropin mRNA in growth hormone-secreting pituitary adenomas and in prolactin-secreting pituitary adenomas by in situ hybridization using a non-isotopic detection method. Acta endocrinologica. vol 128. issue 5. 1993-07-23. PMID:8317187. in all 63 adenomas in acromegaly, gh mrna was revealed in 59 prl mrna and in 36 beta-hcg(lh) mrna. 1993-07-23 2023-08-12 human
K Landin, B Petruson, K E Jakobsson, B A Bengtsso. Skeletal muscle sodium and potassium changes after successful surgery in acromegaly: relation to body composition, blood glucose, plasma insulin and blood pressure. Acta endocrinologica. vol 128. issue 5. 1993-07-23. PMID:8317188. the aim of this study was to investigate the skeletal muscle sodium/potassium (na/k) ratio in acromegaly before and 1 year after trans-sphenoidal removal of a growth hormone (gh)-secreting pituitary adenoma. 1993-07-23 2023-08-12 Not clear
K Landin, B Petruson, K E Jakobsson, B A Bengtsso. Skeletal muscle sodium and potassium changes after successful surgery in acromegaly: relation to body composition, blood glucose, plasma insulin and blood pressure. Acta endocrinologica. vol 128. issue 5. 1993-07-23. PMID:8317188. these changes seem to be mediated by a decreased gh effect on the na/k pump after successful trans-sphenoidal surgery in acromegaly. 1993-07-23 2023-08-12 Not clear
L Fredstorp, S Werne. Growth hormone and insulin-like growth factor-1 in blood and urine as response markers during treatment of acromegaly with octreotide: a double-blind placebo-controlled study. Journal of endocrinological investigation. vol 16. issue 4. 1993-07-20. PMID:8514980. growth hormone (gh), insulin-like growth factor-1 (igf-1) and prolactin (prl) in blood and urine were observed in 20 patients with acromegaly in a double-blind placebo-controlled 14-day clinical trial with the somatostatin analog octreotide. 1993-07-20 2023-08-12 Not clear
L Fredstorp, S Werne. Growth hormone and insulin-like growth factor-1 in blood and urine as response markers during treatment of acromegaly with octreotide: a double-blind placebo-controlled study. Journal of endocrinological investigation. vol 16. issue 4. 1993-07-20. PMID:8514980. in conclusion, this study indicates, that gh and igf-1 in blood are preferable to urinary gh and igf-1 as response markers during treatment of acromegaly with octreotide. 1993-07-20 2023-08-12 Not clear
L Fredstorp, S Werne. Growth hormone and insulin-like growth factor-1 in blood and urine as response markers during treatment of acromegaly with octreotide: a double-blind placebo-controlled study. Journal of endocrinological investigation. vol 16. issue 4. 1993-07-20. PMID:8514980. one disadvantage with urinary assessments of gh and igf-1 in acromegaly seems to be the relatively higher excretion in patients with diabetes mellitus. 1993-07-20 2023-08-12 Not clear
V Chabert-Orsini, G Simonin, T Brue, B Conte-Devolx, P Carayo. [Serum human growth hormone assay. Comparison of six assay kits]. Annales d'endocrinologie. vol 53. issue 4. 1993-07-16. PMID:1305801. we measured 695 sera obtained in short stature children (gh deficiency or normal gh secretory) and adults (normal, hypopituitarism or acromegaly). 1993-07-16 2023-08-11 human
J Hradec, J Marek, J Král, D Simper, J Spáci. Heart in pituitary diseases. Cor et vasa. vol 34. issue 2. 1993-07-08. PMID:1304450. once gh overproduction has been eliminated, cardiac hypertrophy and hypertension can be reversed to a certain stage, a finding highlighting the necessity of instituting treatment of acromegaly as early and as vigorous as possible. 1993-07-08 2023-08-11 Not clear
S Ezzat, S Melmed, D Endres, D R Eyre, F R Singe. Biochemical assessment of bone formation and resorption in acromegaly. The Journal of clinical endocrinology and metabolism. vol 76. issue 6. 1993-07-01. PMID:8501150. the effects of chronic gh and insulin-like growth factor-i (igf-i) excess on bone metabolism were examined by measuring serum markers of bone formation and urine markers of bone resorption as well as vertebral bone densities in patients with active acromegaly. 1993-07-01 2023-08-12 Not clear
A Giustina, M Schettino, S Bossoni, A R Bussi, M Doga, M Licini, W B Wehrenber. Arginine blocks the inhibitory effect of hydrocortisone on circulating growth hormone levels in patients with acromegaly. Metabolism: clinical and experimental. vol 42. issue 5. 1993-06-15. PMID:8492725. in patients with acromegaly, circulating growth hormone (gh) levels and gh responses to gh-releasing hormone (ghrh) are decreased by long-term administration of pharmacological doses of glucocorticoids. 1993-06-15 2023-08-12 Not clear
A Giustina, M Schettino, S Bossoni, A R Bussi, M Doga, M Licini, W B Wehrenber. Arginine blocks the inhibitory effect of hydrocortisone on circulating growth hormone levels in patients with acromegaly. Metabolism: clinical and experimental. vol 42. issue 5. 1993-06-15. PMID:8492725. infusion of hydrocortisone combined either with saline or arginine infusion on circulating gh levels in acromegaly. 1993-06-15 2023-08-12 Not clear
A Giustina, M Schettino, S Bossoni, A R Bussi, M Doga, M Licini, W B Wehrenber. Arginine blocks the inhibitory effect of hydrocortisone on circulating growth hormone levels in patients with acromegaly. Metabolism: clinical and experimental. vol 42. issue 5. 1993-06-15. PMID:8492725. our data show that arginine blocks the inhibitory effect of acute and sustained hypercortisolism on circulating gh levels in acromegaly. 1993-06-15 2023-08-12 Not clear
E F Adams, M Buchfelder, A Hüttner, S Moreth, R Fahlbusc. Recent advances in the molecular biology of growth-hormone secreting human pituitary tumours. Experimental and clinical endocrinology. vol 101. issue 1. 1993-05-24. PMID:8477819. in our own studies, we demonstrate that it is unlikely that a defect within the promoter region of the gh gene will prove to be a cause of excessive gh secretion in acromegaly. 1993-05-24 2023-08-12 human
H Kotzmann, P Bernecker, P Hübsch, P Pietschmann, W Woloszczuk, T Svoboda, G Geyer, A Luge. Bone mineral density and parameters of bone metabolism in patients with acromegaly. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. vol 8. issue 4. 1993-05-20. PMID:8475795. to assess the effect of chronically elevated plasma growth hormone (gh) levels on bone metabolism and bone mineral density (bmd), 16 patients (10 females and 6 males) with a mean age of 49.1 +/- 13.2 years (range 33-68) with active acromegaly were studied and compared to a control group of 16 sex- and age-matched subjects. 1993-05-20 2023-08-12 human
G Turner, R C Brown, I Weeks, G E Butler, F N Creagh, J S Woodhea. Urinary growth hormone excretion as measured by a sensitive immunochemiluminometric assay. Annals of clinical biochemistry. vol 30 ( Pt 2). 1993-05-05. PMID:8466150. there was a good correlation between serum growth hormone (gh) and ugh concentrations in 20 patients with acromegaly and six volunteers following an intravenous injection of recombinant gh. 1993-05-05 2023-08-12 human